DaVita vs Labcorp
DaVita and Labcorp are similar in size: $13.64bn and $13.95bn of revenue in their latest fiscal years. Labcorp grew faster (7.2% against 6.5%). Labcorp kept more of each dollar of sales as profit: a net margin of 6.3% against 5.5%.
| Latest fiscal year | DaVitaDVA, 2025 | LabcorpLH, 2025 |
|---|---|---|
| Revenue | $13.64bn | $13.95bn |
| Revenue growth | 6.5% | 7.2% |
| Net income | $747m | $877m |
| Operating margin | 15.0% | 9.9% |
| Net margin | 5.5% | 6.3% |
| Return on equity | — | 10.5% |
| Free cash flow | $1.31bn | $1.21bn |
| Cash | $676m | $532m |
| Total debt | $10.34bn | $5.58bn |
| Debt to equity | — | 64.8% |
| Dividend per share | — | $2.88 |
| Dividend yield | — | 0.8% |
| Share buybacks | $1.31bn | $450m |
| Employees | 78,000 | — |
| Market value | $11.45bn | $28.61bn |
| Price vs our value range | — | Within our value range |
| Moat score | 62 (Moderate) | 61 (Moderate) |
| Insider trades, 12 months | 0 buys, 10 sales | 0 buys, 20 sales |